| Baydon Earl Hilton, | |
|
1003 Kings Rd, Kirksville, MO 63501-2627 | |
| (336) 327-0645 | |
| Not Available |
| Full Name | Baydon Earl Hilton |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 1003 Kings Rd, Kirksville, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790330371 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 2019024366 (Missouri) | Primary |
| Entity Name | Cleaver Dermatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013452861 PECOS PAC ID: 4587946298 Enrollment ID: O20170116000150 |
News Archive
Angion Biomedica Corp. announced today the establishment of an alliance with Duke University and Massachusetts General Hospital to pursue advanced development and clinical studies of its lead therapeutics for treatment of ischemic stroke.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI).
Ipsen, a global biopharmaceutical group, today announced that its partner Roche today announced the implementation of a risk mitigation plan in the taspoglutide Phase III programme. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
The findings in mice further suggest that particular variants of the protein SH2-B might underlie obesity in humans, the researchers said.
A permanent ban on abortion funding is long overdue, which is why the U.S. bishops support the No Taxpayer Funding of Abortion Act (H.R. 3), said a representative of the United States Conference of Catholic Bishops in a February 8 testimony to the Subcommittee on the Constitution of the House Judiciary Committee.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Baydon Earl Hilton, 1003 Kings Rd, Kirksville, MO 63501-2627 Ph: (336) 327-0645 | Baydon Earl Hilton, 1003 Kings Rd, Kirksville, MO 63501-2627 Ph: (336) 327-0645 |
News Archive
Angion Biomedica Corp. announced today the establishment of an alliance with Duke University and Massachusetts General Hospital to pursue advanced development and clinical studies of its lead therapeutics for treatment of ischemic stroke.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI).
Ipsen, a global biopharmaceutical group, today announced that its partner Roche today announced the implementation of a risk mitigation plan in the taspoglutide Phase III programme. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
The findings in mice further suggest that particular variants of the protein SH2-B might underlie obesity in humans, the researchers said.
A permanent ban on abortion funding is long overdue, which is why the U.S. bishops support the No Taxpayer Funding of Abortion Act (H.R. 3), said a representative of the United States Conference of Catholic Bishops in a February 8 testimony to the Subcommittee on the Constitution of the House Judiciary Committee.
› Verified 8 days ago
Jonathan Lloyd Cleaver, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1316 Country Club Dr, Kirksville, MO 63501 Phone: 660-627-7546 Fax: 660-956-7097 | |
Dr. Lloyd J Cleaver, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1316 Country Club Dr, Kirksville, MO 63501 Phone: 660-627-7546 Fax: 660-956-7097 | |
David Wesley Cleaver, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1316 Country Club Dr, Kirksville, MO 63501 Phone: 660-627-7546 Fax: 660-956-7097 | |
Benjamin Edward Adams, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 700 W Jefferson St, Kirksville, MO 63501 Phone: 660-665-2191 Fax: 660-626-2714 | |
Allison Jessica Goldenstein, DO Dermatology Medicare: Medicare Enrolled Practice Location: 315 S Osteopathy Ave, Kirksville, MO 63501 Phone: 660-785-1000 | |
Jordan Bryan Lane, DO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 315 S Osteopathy Ave, Kirksville, MO 63501 Phone: 660-785-1000 |